| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/NDT/GFR503 |
| P698 | PubMed publication ID | 21911597 |
| P50 | author | Ervin Woodle | Q73677442 |
| P2093 | author name string | Yves Vanrenterghem | |
| Daniel Abramowicz | |||
| Andries J Hoitsma | |||
| Pieter Proot | |||
| FTY720 Phase II Transplant Study Group | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3802-3805 | |
| P577 | publication date | 2011-09-12 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | FTY720 combined with tacrolimus in de novo renal transplantation: 1-year, multicenter, open-label randomized study. | |
| P478 | volume | 26 |
| Q35953902 | A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia. |
| Q39161011 | Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy |
| Q26999417 | Benefits versus risks of latest therapies in multiple sclerosis: a perspective review |
| Q44130980 | Early administration of FTY720 prevents chronic airway as well as vascular destruction in experimental rat lung transplantation |
| Q37675398 | Early tolerability and safety of fingolimod in clinical practice. |
| Q36861092 | Effect of FTY720 (fingolimod) on graft survival in renal transplant recipients: a systematic review protocol. |
| Q53198429 | Effects of FTY720 on peripheral blood lymphocytes and graft infiltrating cells in a rat model of chronic renal allograft rejection. |
| Q37657227 | FTY720 Attenuates Angiotensin II-Induced Podocyte Damage via Inhibiting Inflammatory Cytokines. |
| Q35819965 | FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans |
| Q28068032 | Fingolimod Associated Bilateral Cystoid Macular Edema-Wait and See? |
| Q49480620 | Fingolimod and macular edema: Pathophysiology, diagnosis, and management |
| Q26785848 | Lymphatic disorders after renal transplantation: new insights for an old complication |
| Q37446883 | New immunosuppressive agents in pediatric transplantation |
| Q21296721 | Sphingolipids: a potential molecular approach to treat allergic inflammation |
| Q33555703 | Sphingosine-1-phosphate receptor signaling during acute kidney injury: the tissue is the issue |
| Q38098493 | Targeting cells in motion: migrating toward improved therapies |
| Q85690153 | [Pemphigus. Model disease for targeted therapy] |
Search more.